SRTS News and Press, Sensus Healthcare Inc. From 09/28/23

BOCA RATON, Fla. , Sept. 28, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the shipment of an...

BOCA RATON, Fla, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces its participation in...

2023-08-08 09:22:10 ET Medical device company, Sensus Healthcare ( NASDAQ: SRTS ) Board of Directors has authorized a new share repurchase program under which the company may repurchase up to $3M of its common stock. Joe Sardano, chairman and CEO comments, “We will ...

BOCA RATON, Fla., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its Board of Dire...

2023-08-06 06:14:02 ET Sensus Healthcare, Inc (SRTS) Q2 2023 Earnings Conference Call August 03, 2023, 04:30 PM ET Company Participants Kim Golodetz - IR Joseph Sardano - Chairman and CEO Michael Sardano - President and General Counsel Javier Rampolla - CFO ...

2023-08-03 17:00:26 ET Sensus Healthcare press release ( NASDAQ: SRTS ): Q2 GAAP EPS of -$0.02 beats by $0.06 . Revenue of $4.5M (-62.8% Y/Y) misses by $0.05M . Cash and cash equivalents were $20.1 million as of June 30, 2023, compared with $25.5 million as of ...

Revenues increased 33% and system shipments increased 30%, both compared with the first quarter of 2023 Achieved a milestone with the installation of 700 systems for a total of 708 Expects to ship at least 60 SRT units during 2023 and to return to profitability in the seco...

2023-07-31 01:41:02 ET Summary Sensus Healthcare's stock has been highly sensitive to its earnings reports, with consistent sell-offs following each less-than-stellar quarterly earnings release. Sensus has recently shifted into negative operational cash flow, and its lack of recur...

BOCA RATON, Fla., July 26, 2023 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on ...

Delivery of the SRT-100 marks the expansion of radiotherapy services at Dublin’s Beacon Hospital Non-melanoma skin cancer affects more than 12,000 patients in Ireland annually BOCA RATON, Fla., July 25, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ...